Skip to content
drillr.ai
Sign up

SILO

Silo Pharma, Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.33
−4.90%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue54.1K72.1K72.1K72.1K72.1K
Cost of Revenue310.6K886.1K5.8K5.8K5.8K
Gross Profit(256.5K)(814.0K)66.3K66.3K66.3K
Operating Expenses
R&D Expense2.2M2.2M2.4M845.1K1.3M
SG&A Expense2.0M2.1M2.4M3.1M2.4M
General & Admin Expense2.0M2.1M2.4M3.1M2.4M
Selling & Marketing Expense—————
Other Expenses—(841.8K)——(20.0K)
Total Operating Expenses4.2M3.5M4.8M3.9M3.7M
Cost and Expenses4.5M4.4M4.8M3.9M3.7M
Operating Income (EBIT)(4.5M)(4.3M)(4.7M)(3.9M)(3.6M)
Non-Operating
Interest Income165.0K193.9K333.2K398.5K72.6K
Interest Expense39.8K37.3K5.1K4.9K2.2K
Net Interest Income125.2K156.6K328.1K393.7K70.4K
Other Non-Op Income/Expense(10.3K)53.0K312.8K224.5K(279.7K)
Non-Operating Income (excl Interest)129.3K(90.3K)(317.9K)(229.4K)277.5K
EBT (Pre-Tax Income)(4.5M)(4.2M)(4.4M)(3.6M)(3.9M)
Income Tax Expense—————
Bottom Line
Net Income(4.5M)(4.2M)(4.4M)(3.7M)(3.9M)
Earnings from Cont. Ops(4.5M)(4.2M)(4.4M)(3.6M)(3.9M)
Earnings from Discont. Ops———(69.6K)(1.2K)
Bottom Line Net Income(4.5M)(4.2M)(4.4M)(3.7M)(3.9M)
Per Share
Basic EPS($5.35)($7.50)($17.85)($18.00)($25.65)
Diluted EPS($5.35)($7.50)($17.85)($18.00)($25.65)
Revenue Per Share$0.05$0.13$0.29$0.35$0.47
Shares
Basic Shares Outstanding1.1M558818245359205325152283
Diluted Shares Outstanding1.1M558818245359205325152283
Profitability Metrics
EBITDA(4.6M)(4.2M)(4.4M)(3.6M)(3.9M)
D&A11.8K11.4K6.2K——
EBIT(4.6M)(4.2M)(4.4M)(3.6M)(3.9M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026